Zobrazeno 1 - 10
of 550
pro vyhledávání: '"63"'
Autor:
Robert David Lewis, Bachar Samra, Edwin Chiu, Babak Baseri, Gurinder Sidhu, Iuliana Shapira, Jason Gonsky, Evelyn Taiwo, Ahmed Sawas, Bo Lin, Eric Tam
Publikováno v:
Blood. 132:2906-2906
Background: Adult T-Cell Lymphoma/Leukemia (ATLL) is a rare and aggressive HTLV-1 related peripheral T-cell lymphoma that occurs predominantly in Japan and the Caribbean basin. Acute (A) and lymphomatous (L) subtypes are the most aggressive forms wit
Autor:
Yves Beguin, Stéphanie Nguyen, Eric Deconinck, Anne-Claire Mamez, Luc Fornecker, Pascal Turlure, Didier Blaise, Felipe Suarez, Norbert Ifrah, Anne Huynh, Mohamad Mohty, Jacques-Olivier Bay, Sébastien Maury, Thierry Lamy, Gaelle Guillerm, Stephane Vigouroux, Laure Vincent, Ibrahim Yakoub-Agha, Nathalie Contentin, Natacha Maillard, Vincent Levy, Jean-Yves Cahn, Patrice Chevallier, Aliénor Xhaard
Publikováno v:
Blood. 124:3963-3963
Introduction: Peripheral T-cell lymphomas (PTCL) are heterogeneous diseases, lightly sensitive to chemotherapy, with an adverse outcome and a 5-year survival rate of about 30%. Allogeneic hematopoietic stem cell transplant (allo-SCT) can lead to dura
Autor:
Magali Le Garff-Tavernier, Véronique Leblond, Andrea Toma, Hélène Merle-Béral, Martine Brissard, Lucile Musset, Nabih Azar, Patrick Bonnemye
Publikováno v:
Blood. 110:4399-4399
The immunophenotypic characterization of Waldenstrom’s macroglobulinemia (WM) is still unclear, despite being an essential tool in the diagnosis of hematological malignancies. We retrospectively reviewed the immunophenotypic profile of 63 cases of
Autor:
Sol Schulman, Daniel J. Hampshire, Jennifer Jolley, Peter A. Smethurst, Willem H. Ouwehand, Alan T. Nurden, Ilenia Simeoni, William Stevenson, Paolo Gresele, Ri Liesner, Kathleen Freson, Christel Van Geet, Walter H. A. Kahr, Tadbir K. Bariana, Paquita Nurden, Minka J A Vries, David A. Wilcox, Mary Mathias, Fengyuan Hu, Maha Othman, Marguerite Neerman-Arbez, Pawan Poudel, Matthias Ballmaier, Pieter H. Reitsma, Peter William Collins, Jose A. Lopez, Artur J. Szkotak, Jose A. Guerrero, Marie-Christine Alessi, Manuela Germeshausen, Jonathan Stephens, Cedric Ghevaert, Michael Gattens, Carolyn M. Millar, Gareth Baynam, Marian Hill, Marco Cattaneo, Antony P. Attwood, Shoshana Revel-Vilk, Matthew T. Rondina, Anne M. Kelly, Sri V V Deevi, Sofia Papadia, Amit C. Nathwani, Paul F. Bray, Daniel B. Bellissimo, Michael Laffan, Deborah L. French, Daniel P. Hart, Shinji Kunishima, Bin Zhang, Rutendo Mapeta, Salih Tuna, Anne Goodeve, Keith Gomez, Nancy Hogg, Ernest Turro, Johan W. M. Heemskerk, Marta Bertoli, Karyn Megy, Ron Kerr, Christopher J. Penkett, David J. Perry, Claire Lentaigne, Deborah Whitehorn, Daniel Greene, Suthesh Sivapalaratnam, Myrto Kostadima, Andrew D Mumford, Bruce Furie, Emilse Bermejo, Rémi Favier, Michele P. Lambert, Louise C. Daugherty, Yvonne M. C. Henskens, Augusto Rendon, Loredana Bury, Kathelijne Peerlinck, Sarah K Westbury
Publikováno v:
Blood
Blood, American Society of Hematology, 2016, 127 (23), pp.2791-803. ⟨10.1182/blood-2015-12-688267⟩
Simeoni, I, Stephens, J C, Hu, F, Deevi, S V V, Megy, K, Bariana, T K, Lentaigne, C, Schulman, S, Sivapalaratnam, S, Vries, M J A, Westbury, S K, Greene, D, Papadia, S, Alessi, M-C, Attwood, A P, Ballmaier, M, Baynam, G, Bermejo, E, Bertoli, M, Bray, P F, Bury, L, Cattaneo, M, Collins, P, Daugherty, L C, Favier, R, French, D L, Furie, B, Gattens, M, Germeshausen, M, Ghevaert, C, Goodeve, A, Guerrero, J, Hampshire, D J, Hart, D P, Heemskerk, J W M, Henskens, Y M C, Hill, M, Hogg, N, Jolley, J D, Kahr, W H, Kelly, A M, Kerr, R, Kostadima, M, Kunishima, S, Lambert, M P, Liesner, R, Lopez, J, Mapeta, R P, Mathias, M, Millar, C M, Nathwani, A, Neerman-Arbez, M, Nurden, A T, Nurden, P, Othman, M, Peerlinck, K, Perry, D J, Poudel, P, Reitsma, P, Rondina, M, Smethurst, P A, Stevenson, W, Szkotak, A, Tuna, S, van Geet, C, Whitehorn, D, Wilcox, D A, Zhang, B, Revel-Vilk, S, Gresele, P, Bellissimo, D, Penkett, C J, Laffan, M A, Mumford, A D, Rendon, A, Gomez, K, Freson, K, Ouwehand, W H & Turro, E 2016, ' A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorderdisorders ', Blood, vol. 127, no. 23, pp. 2791-2803 . https://doi.org/10.1182/blood-2015-12-688267
Blood, 127(23), 2791-2803
Blood, 127(23), 2791-2803. The American Society of Hematology
Blood, American Society of Hematology, 2016, 127 (23), pp.2791-803. ⟨10.1182/blood-2015-12-688267⟩
Simeoni, I, Stephens, J C, Hu, F, Deevi, S V V, Megy, K, Bariana, T K, Lentaigne, C, Schulman, S, Sivapalaratnam, S, Vries, M J A, Westbury, S K, Greene, D, Papadia, S, Alessi, M-C, Attwood, A P, Ballmaier, M, Baynam, G, Bermejo, E, Bertoli, M, Bray, P F, Bury, L, Cattaneo, M, Collins, P, Daugherty, L C, Favier, R, French, D L, Furie, B, Gattens, M, Germeshausen, M, Ghevaert, C, Goodeve, A, Guerrero, J, Hampshire, D J, Hart, D P, Heemskerk, J W M, Henskens, Y M C, Hill, M, Hogg, N, Jolley, J D, Kahr, W H, Kelly, A M, Kerr, R, Kostadima, M, Kunishima, S, Lambert, M P, Liesner, R, Lopez, J, Mapeta, R P, Mathias, M, Millar, C M, Nathwani, A, Neerman-Arbez, M, Nurden, A T, Nurden, P, Othman, M, Peerlinck, K, Perry, D J, Poudel, P, Reitsma, P, Rondina, M, Smethurst, P A, Stevenson, W, Szkotak, A, Tuna, S, van Geet, C, Whitehorn, D, Wilcox, D A, Zhang, B, Revel-Vilk, S, Gresele, P, Bellissimo, D, Penkett, C J, Laffan, M A, Mumford, A D, Rendon, A, Gomez, K, Freson, K, Ouwehand, W H & Turro, E 2016, ' A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorderdisorders ', Blood, vol. 127, no. 23, pp. 2791-2803 . https://doi.org/10.1182/blood-2015-12-688267
Blood, 127(23), 2791-2803
Blood, 127(23), 2791-2803. The American Society of Hematology
Inherited bleeding, thrombotic and platelet disorders (BPDs) are diseases affecting approximately 300 individuals per million births. With the exception of haemophilia and von Willebrand disease patients, a molecular analysis for patients with a BPD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa352cd1eafdc5697d70b553f05b0503
http://hdl.handle.net/11391/1386441
http://hdl.handle.net/11391/1386441
Autor:
Vittorio Krogh, Rudolf Kaaks, Yvonne T. van der Schouw, Gianluca Severi, Eva Ardanaz, Marc J. Gunter, Tilman Kühn, Nicholas J. Wareham, Timothy J. Key, Francesca Mancini, Carlotta Sacerdote, María José Sánchez, Heiner Boeing, Annemieke M.W. Spijkerman, Peter M. Nilsson, Guy Fagherazzi, Miren Dorronsoro, María Dolores Chirlaque, Kay-Tee Khaw, Olov Rolandsson, Stephen J. Sharp, Salvatore Panico, Domenico Palli, Nita G. Forouhi, Christiane S. Hampe, Claudia Langenberg, Kim Overvad, Rosario Tumino, Elio Riboli
Publikováno v:
Rolandsson, O, Hampe, C S, Sharp, S J, Ardanaz, E, Boeing, H, Fagherazzi, G, Mancini, F R, Nilsson, P M, Overvad, K, Chirlaque, M-D, Dorronsoro, M, Gunter, M J, Kaaks, R, Key, T J, Khaw, K-T, Krogh, V, Kühn, T, Palli, D, Panico, S, Sacerdote, C, Sánchez, M-J, Severi, G, Spijkerman, A M W, Tumino, R, van der Schouw, Y T, Riboli, E, Forouhi, N G, Langenberg, C & Wareham, N J 2020, ' Autoimmunity plays a role in the onset of diabetes after 40 years of age ', Diabetologia, vol. 63, no. 2, pp. 266-277 . https://doi.org/10.1007/s00125-019-05016-3
Diabetologia
Diabetologia, Springer Verlag, 2020, 63 (2), pp.266-277. ⟨10.1007/s00125-019-05016-3⟩
Diabetologia, 63, 266. Springer Verlag
Diabetologia
Diabetologia, Springer Verlag, 2020, 63 (2), pp.266-277. ⟨10.1007/s00125-019-05016-3⟩
Diabetologia, 63, 266. Springer Verlag
Aims/hypothesis Type 1 and type 2 diabetes differ with respect to pathophysiological factors such as beta cell function, insulin resistance and phenotypic appearance, but there may be overlap between the two forms of diabetes. However, there are rela
Autor:
Sandhya Nagarakanti, Ki Lee, Corinne Raczek, Sharif Mohammed, Alexis K. Okoh, Yan Cheng, Alice J. Cohen, Amin Krushna
Publikováno v:
Blood
Introduction: Early studies from Wuhan, China have reported an association between blood type and outcomes in COVID-19 infected patients. Conflicting reports in literature have investigated the protective role of blood type O against worst outcomes a
Autor:
Yannick Allanore, Alessandro Giollo, Patricia Carreira, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Daniel E. Furst, M. De Santis, F. Tirelli, Cathrine Brunborg, Rosario Foti, G. De Luca, Elisabetta Zanatta, N. Del Papa, Marco Matucci-Cerinic, C. Mihai, Arsène Mekinian, Oliver Distler, Madelon C. Vonk, Corrado Campochiaro, M. G. Lazzaroni, Paolo Airò
Publikováno v:
Annals of the Rheumatic Diseases. 80:232.2-233
Background:Coronavirus disease-19 (COVID-19) has been a major clinical challenge worldwide. Sex, age and comorbidities have been associated with worse outcome in the general population. Systemic sclerosis (SSc) is a severe, autoimmune disease with fr
Autor:
Theresa Bruegmann, Rusmir Husic, Barbara Dreo, Winfried Graninger, Philipp Bosch, Angelika Lackner, Johannes Fessler, Martin H Stradner
Publikováno v:
Saturday, 15 June 2019.
Background: In rheumatoid arthritis (RA) stratification is considered an important step towards the development of patient-tailored therapeutic concepts. The fact that less than 50% of RA patients experience a substantial improvement in response to a
Autor:
Yanhong Deng, Lynn E. Fiellin, E. Jennifer Edelman, David A. Fiellin, Vincent C. Marconi, Roger Bedimo, James Dziura, Janet P. Tate, Patrick G. O'Connor, Kendall J. Bryant, David Rimland, Michael S. Simberkoff, Nathan B. Hansen, Cynthia L. Gibert, Maria C. Rodriguez-Barradas, Amy C. Justice, Stephen A. Maisto, Christopher J. Cutter
Publikováno v:
Lancet HIV
Summary Background We examined the effectiveness of integrated stepped alcohol treatment (ISAT) on alcohol use and HIV outcomes among patients living with HIV and alcohol use disorder. Methods In this multisite, randomised controlled trial, conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cebf9e07b5d01c05dfb7b206adba015e
https://europepmc.org/articles/PMC7161741/
https://europepmc.org/articles/PMC7161741/
Publikováno v:
Leukemia & Lymphoma. 57:797-802
Background Dyslipidemia and metabolic syndrome are risk factors for cancer, and clinically aggressive CLL cells are believed to rely on lipid metabolism. Statins promote apoptosis and inhibit CLL cell growth in pre-clinical models, and statin use dur